FEATURED ARTICLES

• How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

  Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

• Fear Isn't A Strategy: Rethinking AI In Clinical Trials

  As AI restrictions rise, needed oversight is slowing trials. This piece explores how delays hurt patients and how sites and sponsors can modernize without sacrificing regulatory trust.

• 5 Questions Every Sponsor Must Ask Before Selecting An eTMF Platform

  Lean teams need a strategic eTMF choice. The right platform speeds startup, cuts manual oversight, strengthens site collaboration, and keeps studies inspection‑ready as portfolios grow.

• Redefining Site Feasibility

  Site feasibility is becoming a major source of startup delays as early requests, pre‑award outreach, and unclear communication create inaccurate projections and wasted effort.

• 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives

  AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

• State Of Clinical Trial Technology: The AI Inflection Point

  Digital maturity gaps are widening in clinical research. Connected workflows speed insights and execution, while manual processes leave organizations increasingly behind.

• We Need Regulatory Clarity—Not Complexity In Clinical Trial Technology

  The current U.S. deregulatory momentum should not diminish compliance standards but instead serve as a call to streamline and modernize regulatory guidance.

• Five Ways Site-Facing Technology Helps Sponsors And CROs

  Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.

• Navigating Regulatory And Privacy Updates In Clinical Trials

  Explore how the guide for eRegulatory adoption in Canada provides resources to help stakeholders navigate these changes and enhance participant engagement and retention in clinical trials.

• eTMFs Uncovered: 5 Costly Misconceptions To Avoid

  Critically examine prevalent myths surrounding electronic Trial Master Files (eTMFs) and their integration with electronic Investigator Site Files (eISFs).